PRIMARY STUDY
Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment
Key Findings: This study shows that abnormal cannabidiol (Abn-CBD) protects against TNBS-induced colitis in mice by promoting endothelial and epithelial wound healing and inhibiting neutrophil recruitment, highlighting its therapeutic potential for intestinal inflammatory diseases.
Type of Study: Animal Study
Study Result: Positive
Research Location(s): Canada, Germany, Poland
Year of Pub: 2025
Cannabinoids Studied: Abnormal Cannabidiol (Abn-CBD)
Phytocannabinoid Source: Not Applicable
Chemotype: , Chemotype III
Citation: Krohn RM, Parsons SA, Fichna J, Patel KD, Yates RM, Sharkey KA, Storr MA. Abnormal cannabidiol attenuates experimental colitis in mice, promotes wound healing and inhibits neutrophil recruitment. J Inflamm (Lond). 2016 Jul 14;13:21. doi: 10.1186/s12950-016-0129-0. PMID: 27418880; PMCID: PMC4944257.
